Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19104


This study will evaluate naltrexone and cognitive-behavioral therapy treatments for alcohol dependence and post-traumatic stress disorder (PTSD). Subjects will be randomly assigned a 6-month treatment of either: 1) naltrexone alone, 2) naltrexone with PTSD psychosocial therapy, 3) a placebo with PTSD psychosocial therapy, or 4) placebo alone. An enhanced medication management intervention will accompany all treatment conditions. Follow-up assessments will be completed at 9 and 12 months after treatment.


Inclusion Criteria: - Meets criteria for alcohol dependence and post-traumatic stress disorder. - Heavy drinking in the past 30 days (an average of more than 12 alcohol drinks per week with at least 1 day of 4 or more drinks). - Successfully complete medical detoxification. - Exhibit clinically significant trauma-related symptoms. - Live in a commutable distance to the University of Pennsylvania and agree to follow-up visits. - Aged between 18 and 65 years old. - Able to provide an informed consent. - Speak and read English. Exclusion Criteria: - Current diagnosis of any substance dependence other than alcohol, nicotine, or cannabis. - Evidence of opiate use in the past 30 days. - Significant risk of violence or history of serious violent behavior during the past year. - Continued contact with an intimate partner if assault by the partner is the index trauma. - Changes in dosage or medication for any SSRI treatment in the three months prior to entering the study. - Unstable or serious medical illness. - Current severe psychiatric symptom. - Mental retardation or another pervasive developmental disorder. - Use of an investigational medication in the past 30 days. - Pregnant, nursing or not using reliable contraception.



Primary Contact:

Principal Investigator
Edna B. Foa, PhD
University of Pennsylvania

Backup Contact:


Location Contact:

Philadelphia, Pennsylvania 19104
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.